As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 2/13/24‡ Lind Global Fund II LP            SC 13G      2/13/24    2:93K  Wisa Technologies, Inc.           Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Macro Fund LP³
          Lind Global Partners II LLC³
          Lind Global Partners LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:65K  Windtree Therapeutics Inc./DE     Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:67K  Versus Systems Inc.               Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:65K  T2 Biosystems, Inc.               Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:65K  Toughbuilt Industries, Inc.       Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:93K  Siyata Mobile Inc.                Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Macro Fund LP³
          Lind Global Partners II LLC³
          Lind Global Partners LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:67K  SenesTech, Inc.                   Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:65K  SMX (Security Matters) plc        Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:64K  Sintx Technologies, Inc.          Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:64K  Transcode Therapeutics, Inc.      Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:65K  Revelation Biosciences, Inc.      Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:65K  Quoin Pharmaceuticals, Ltd.       Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:67K  PaxMedica, Inc.                   Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:64K  Polar Power, Inc.                 Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:64K  Panbela Therapeutics, Inc.        Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:66K  Palisade Bio, Inc.                Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:66K  Invivo Theraps Holdings Corp.     Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:67K  Mobiquity Technologies, Inc.      Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:67K  Kiora Pharmaceuticals Inc.        Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³
 2/13/24‡ Lind Global Fund II LP            SC 13G/A    2/13/24    2:67K  Intelligent Bio Solutions Inc.    Bingham McCutchen LLP/FA 
          Jeff Easton³
          Lind Global Partners II LLC³

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Type:
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.